tiprankstipranks
Shaftesbury Capital (GB:SHC)
LSE:SHC
Holding GB:SHC?
Track your performance easily

Shaftesbury Capital (SHC) Income Statement

12 Followers

Shaftesbury Capital Income Statement

Last quarter (Q4 2022), Shaftesbury Capital's total revenue was £―, a decrease of ― from the same quarter last year. In Q4, Shaftesbury Capital's net income was £―. See Shaftesbury Capital’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
-£ 195.10M£ 74.10M£ 68.00M£ 73.90M£ 77.60M
Cost of Revenue
-£ 53.20M£ 16.80M£ 15.90M£ 16.20M£ 16.50M
Gross Profit
-£ 141.90M£ 57.30M£ 52.10M£ 57.70M£ 61.10M
Operating Expense
-£ 40.00M£ 26.00M£ 19.30M£ 39.50M£ 31.90M
Operating Income
-£ 255.90M£ 31.30M£ 32.80M£ 18.20M£ 29.20M
Net Non Operating Interest Income Expense
-£ -79.10M£ -27.60M£ 24.90M£ -3.70M£ -8.80M
Other Income Expense
-£ -768.90M£ 209.50M---
Pretax Income
-£ 750.60M£ -205.80M£ 30.00M£ -704.70M£ -61.30M
Tax Provision
-£ 200.00K£ 6.00M£ 700.00K£ -1.00M£ 1.00M
Earnings From Equity Interest Net Of Tax
-£ 200.00K£ 13.50M---
Net Income Common Stockholders
-£ 750.40M£ -211.80M£ 29.30M£ -702.70M£ -253.60M
Basic EPS
-£ 0.46--£ -0.82£ -0.30
Diluted EPS
-£ 0.45--£ -0.82£ -0.30
Basic Average Shares
-£ 1.65B--£ 852.00M£ 853.00M
Diluted Average Shares
-£ 1.66B--£ 852.40M£ 854.20M
Dividend Per Share
-£ 0.01--£ 0.01£ 0.01
Total Operating Income As Reported
------
Reported Normalized Basic E P S
----£ 0.02£ 0.01
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
----£ 58.00M£ 16.50M
Total Expenses
-£ 93.20M-£ -35.20M£ 55.70M£ 48.40M
Net Income From Continuing And Discontinued Operation
-£ 750.40M£ -211.80M£ 29.30M£ -702.70M£ -253.60M
Normalized Income
-£ 570.85M£ -166.70M£ 21.40M£ -677.64M£ 20.98M
Interest Expense
----£ 24.10M£ 21.20M
EBIT
-£ 818.10M£ -178.60M£ 61.70M£ -680.60M£ -40.10M
EBITDA
-£ 818.60M£ -181.00M£ 61.70M£ -679.10M£ -38.80M
Currency in GBP

Shaftesbury Capital Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis